A case of pembrolizumab-induced autoimmune haemolytic anaemia with polymyalgia rheumatica

We report the case of a patient treated with pembrolizumab, who developed autoimmune haemolytic anaemia (AIHA) and polymyalgia rheumatica (PMR).

Source: European Journal of Cancer - October 1, 2018 Category: Cancer & Oncology Authors: Bertrand Robilliard, Erik Arnaud, Lauris Gastaud, Jonathan Broner Tags: Letter to the Editor Source Type: research